Detalhe da pesquisa
1.
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.
Invest New Drugs
; 29(2): 316-22, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19997959
2.
Reaction chemistry of metallotexaphyrins: the synthesis and characterization of the first meso-oxotexaphlorin.
Chem Commun (Camb)
; (7): 678-9, 2002 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-12119671
3.
Quantitation of motexafin lutetium in human plasma by liquid chromatography-tandem mass spectrometry and inductively coupled plasma-atomic emission spectroscopy.
AAPS PharmSci
; 5(3): E23, 2003.
Artigo
Inglês
| MEDLINE | ID: mdl-14621958
4.
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer.
J Thorac Oncol
; 6(4): 786-9, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21289521
5.
Validation and use of three complementary analytical methods (LC-FLS, LC-MS/MS and ICP-MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues.
Anal Bioanal Chem
; 385(2): 345-56, 2006 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16609840
6.
A Schiff base expanded porphyrin macrocycle that acts as a versatile binucleating ligand for late first-row transition metals.
Inorg Chem
; 44(7): 2125-7, 2005 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-15792442